Yuhan Corporation (000105.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenKRW 66,700.00

From 52W high−41.13%

Volume351.00

Market capKRW 5.39T

P/E (TTM)23.3x

P/S (TTM)2.4x

Div yield0.91%

Key dataSep 18, 2026

Open

KRW 66,700.00

From 52W high

−41.13%

Volume

351.00

Market cap

KRW 5.39T

ValuationView details →

P/E (Fwd)

44.6x

EV/EBITDA

24.5x

P/E (TTM)

23.3x

RSI (14)

40.4

MomentumView details →

1D Return

−0.30%

YTD Return

−34.85%

ValuationView details →

P/E (Fwd)

44.6x

P/E (TTM)

23.3x

EV/EBITDA

24.5x

EV/Sales

2.4x

P/S (TTM)

2.4x

P/B (TTM)

2.3x

ProfitabilityView details →

Gross Margin

34.30%

Net Margin

10.39%

EBITDA Margin

9.63%

ROE (TTM)

9.93%

ROA (TTM)

7.12%

Asset Turnover

0.69x

GrowthView details →

Revenue YoY

+5.40%

EPS YoY

+166.62%

FCF YoY

+120.39%

Revenue CAGR 3Y

+7.18%

EPS CAGR 3Y

+29.14%

EBITDA YoY

−21.32%

MomentumView details →

1D Return

−0.30%

YTD Return

−34.85%

1Y Return

−37.08%

RSI (14)

40.4

vs 50D SMA

+0.64%

vs 200D SMA

−18.16%

Capital & dividendView details →

Debt/Equity

0.15x

Current Ratio

2.27x

Quick Ratio

1.68x

Div Yield

0.91%

Div Rate

KRW 610.00

Div Growth 1Y

+19.61%

EarningsView details →

EPS (Actual)

KRW 937.90

EPS Surprise

37.66%

Beats (12Q)

1/12

Next Q EPS Est

KRW 328.20

Avg Surprise (4Q)

37.66%

Rev Surprise

2.67%

Financials snapshotView financials →

Revenue (TTM)

2.28T

Net Income (TTM)

237.09B

Op. CF (TTM)

165.66B

Next earningsNov 3, 2026 →

Latest newsMore news →

No recent news for 000105.KS.

Similar companies

Yuhan Corporation000100.KS Hanmi Pharm. Co., Ltd.128940.KS Hanall Biopharma Co.,Ltd009420.KS Celltrion Pharm, Inc.068760.KQ Daewoong pharmaceutical Co.,Ltd069620.KS JW Pharmaceutical Corporation001067.KS Find similar companies →

Latest newsMore news →

No recent news for 000105.KS.